These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1072 related articles for article (PubMed ID: 29301251)

  • 41. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
    Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inflammatory resolution and vascular barrier restoration after retinal ischemia reperfusion injury.
    Abcouwer SF; Shanmugam S; Muthusamy A; Lin CM; Kong D; Hager H; Liu X; Antonetti DA
    J Neuroinflammation; 2021 Aug; 18(1):186. PubMed ID: 34446062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of VEGF-A in endothelial phenotypic shift in human diabetic retinopathy and VEGF-A-induced retinopathy in monkeys.
    Hofman P; Blaauwgeers HG; Vrensen GF; Schlingemann RO
    Ophthalmic Res; 2001; 33(3):156-62. PubMed ID: 11340407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelial F-actin cytoskeleton in the retinal vasculature of normal and diabetic rats.
    Yu PK; Yu DY; Cringle SJ; Su EN
    Curr Eye Res; 2005 Apr; 30(4):279-90. PubMed ID: 16020258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes.
    Jiang F; Chen Q; Huang L; Wang Y; Zhang Z; Meng X; Liu Y; Mao C; Zheng F; Zhang J; Yan H
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats.
    Sohn E; Kim J; Kim CS; Lee YM; Kim JS
    Nutrients; 2016 Mar; 8(3):140. PubMed ID: 26950148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatostatin protects human retinal pericytes from inflammation mediated by microglia.
    Mazzeo A; Arroba AI; Beltramo E; Valverde AM; Porta M
    Exp Eye Res; 2017 Nov; 164():46-54. PubMed ID: 28734673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy.
    Rolev KD; Shu XS; Ying Y
    Neuropharmacology; 2021 Apr; 187():108498. PubMed ID: 33582150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-inflammatory role of sesamin in STZ induced mice model of diabetic retinopathy.
    Ahmad S; ElSherbiny NM; Jamal MS; Alzahrani FA; Haque R; Khan R; Zaidi SK; AlQahtani MH; Liou GI; Bhatia K
    J Neuroimmunol; 2016 Jun; 295-296():47-53. PubMed ID: 27235348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina.
    Mohammad G; Siddiquei MM; Othman A; Al-Shabrawey M; Abu El-Asrar AM
    Exp Eye Res; 2013 Feb; 107():101-9. PubMed ID: 23261684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An in vitro cell model to study microglia activation in diabetic retinopathy.
    Xie H; Zhang C; Zhang J; Xu Y; Liu K; Luo D; Qiu Q; Xu GT; Zhang J
    Cell Biol Int; 2022 Jan; 46(1):129-138. PubMed ID: 34647397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy.
    Chakravarthy H; Beli E; Navitskaya S; O'Reilly S; Wang Q; Kady N; Huang C; Grant MB; Busik JV
    PLoS One; 2016; 11(1):e0146829. PubMed ID: 26760976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of Inflammation in Diabetic Retinopathy.
    Rübsam A; Parikh S; Fort PE
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565290
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anomalies in neurovascular coupling during early diabetes: A review.
    Fletcher EL; Dixon MA; Mills SA; Jobling AI
    Clin Exp Ophthalmol; 2023 Jan; 51(1):81-91. PubMed ID: 36349522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD74 indicates microglial activation in experimental diabetic retinopathy and exogenous methylglyoxal mimics the response in normoglycemic retina.
    Wang J; Lin J; Schlotterer A; Wu L; Fleming T; Busch S; Dietrich N; Hammes HP
    Acta Diabetol; 2014 Oct; 51(5):813-21. PubMed ID: 24974304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCζ in the Goto Kakizaki rat model.
    Omri S; Behar-Cohen F; de Kozak Y; Sennlaub F; Verissimo LM; Jonet L; Savoldelli M; Omri B; Crisanti P
    Am J Pathol; 2011 Aug; 179(2):942-53. PubMed ID: 21712024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
    Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
    Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attenuating Diabetic Vascular and Neuronal Defects by Targeting P2rx7.
    Pavlou S; Augustine J; Cunning R; Harkin K; Stitt AW; Xu H; Chen M
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy.
    Xu C; Liu G; Liu X; Wang F
    Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.